Bronchiolitis Obliterans Syndrome (BOS) Terminated Phase 2 / 3 Trials for Cyclosporine (DB00091)

Also known as: Obliterative Bronchiolitis / Bronchiolitis Obliterans / Bronchiolitis Obliterans (BO) / Bronchiolitis Obliterans Syndrome / Obliterative bronchiolitis (disorder)

IndicationStatusPhase
DBCOND0071683 (Bronchiolitis Obliterans Syndrome (BOS))Terminated2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01334892L-CsA in the Prevention of Bronchiolitis Obliterans Syndrome (BOS) in Lung Transplant (LT) PatientsPrevention